GAGA Share Market News

[hfe_template id='11223'] [ad_1] Indian pharmaceutical stocks fell up to 3% on the BSE on Thursday amid fears of tariffs by US President Donald Trump, with a fresh setback from the announcements in the auto sector having a rub-off impact. Shares of Aurobindo Pharmaceuticals fell 2% to their day’s low of Rs 1,132.75 while those of Ipca Laboratories went down by 2.7% to Rs 1,403.95. Sun Pharmaceuticals and Dr Reddy’s Laboratories shares tumbled 1.7% each and Ajanta Pharma shares slid by 2.5%. Meanwhile, the shares of Zydus Lifesciences, Alkem Laboratories, Lupin, and Natco Pharma were trading lower between 1% and 1.5% around 10:20 am. Speaking to reporters at the White House, Trump, in a previous speech, said the United States would need all those products if there were problems including wars. "We've been ripped off by every country," Trump said as he presided over a meeting of his Cabinet. Live Events Commerce Secretary Howard Lutnick, during the same meeti...

[hfe_template id='11223'] [ad_1] Promoted by the family of Namita Thapar of the 'Shark Tank' fame, Emcure Pharma is the 13th largest player in the Indian pharmaceutical market. The Pune-based company is rolling out a ₹1,952 crore initial public offering comprising a fresh issue of ₹800 crore and an offer of sale (OFS) of ₹1,152 crore. The IPO represents 10.2% of the post-paid-up capital of the company. The proceeds of the issue are going to be used to repay debt to the tune of ₹600 crore. Among the promoters selling in the OFS, the chief executive Satish Mehta is selling 420,000 shares amounting to ₹42.3 crore at the upper price band, while executive director Namita Thapar is selling 1,268,600 shares amounting to ₹127.8 crore. Business : Set up in 1981 by Satish Mehta, Emcure Pharma today has grown to be the largest pharma company in the gynaecology and HIV therapeutic areas in India. Sixteen of its top 20 brands are ranked among the top three highest-selling bra...